Strategas sees healthcare outperforming in 2025
The healthcare sector is poised to see a rebound and lead the market this year, according to analysts at Strategas,…
Biotechnology and pharmaceuticals
UnitedHealthcare Names Tim Noel New CEO After Brian Thompson Killing
UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon | AFP…
Mergers and acquisitions in biotech and pharmaceuticals will recover in 2025
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on December 5, 2023. New York Stock Exchange Group…
FDA approves Johnson & Johnson's Spravato nasal spray for depression
This photo provided by Janssen Global Services shows Spravato nasal spray. Janssen Global Services via AP The Food and Drug…
Medicare's $2,000 prescription drug limit can save members thousands: AARP
Most Medicare patients who met the new $2,000 limit on out-of-pocket costs for prescription drugs could see massive savings, despite…
Stocks rise on cold inflation, hot bank profits and new rules on biotech exports to China
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Anti-schizophrenia drug Cobenfy could treat Alzheimer's
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…
Eli Lilly and Amazon announce agreements at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Eli Lilly LLY cuts 2024 revenue outlook for weight-loss drugs
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, Thursday, Nov. 14, 2024.…
Eli Lilly CEO Hopes New Weight-Loss Pill Approved Next Year
David Ricks, CEO of Eli Lilly Scott Mlyn | CNBC Eli Lilly It expects its experimental weight-loss pill to be…